GlassScriptPhysician profile
George T Ho
NPI 1255390852
$71,522.35
in general payments reported to CMS, 2019-2025
34 companies · $419 in 2025
The $419 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $18K · 2021: $11K · 2022: $14K · 2023: $3,072 · 2024: $881 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,545 · Travel and Lodging: $1,805 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,545.25 |
| Travel and Lodging | $1,805.20 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $40,859.11 | 2019-2023 | Xtandi |
| Pfizer INC. | $22,367.63 | 2019-2024 | |
| Axonics, INC. | $2,743.43 | 2022-2024 | Axonics, Bulkamid |
| Neotract INC. | $931.81 | 2019-2020 | |
| Teleflex LLC | $688.12 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $568.29 | 2021-2025 | Ams 700, Greenlight Xps, General - Therapies |
| Dentsply Ih INC. | $373.02 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $371.23 | 2021-2022 | |
| Procept Biorobotics Corporation | $367.65 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Myovant Sciences INC. | $257.44 | 2021 | |
| Foundation Medicine, INC. | $245.55 | 2022-2023 | |
| Rochester Medical Corporation | $175.81 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $175.24 | 2022-2023 | Pylarify |
| Medtronic, INC. | $152.70 | 2022 | |
| Bluewind Medical | $149.29 | 2025 | Revi |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $124.27 | 2023 | Cvac Aspiration System |
| Janssen Biotech, INC. | $123.61 | 2019-2021 | |
| Blue Earth Diagnostics | $120.92 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.57 | 2019-2022 | |
| Photocure INC | $117.40 | 2025 | Cysview |
| Medtronic USA, INC. | $114.78 | 2020 | |
| Dentsply Ih Ab | $87.97 | 2023-2024 | Lofric, Lofric |
| Abbvie INC. | $69.43 | 2020-2021 | |
| Dendreon Pharmaceuticals LLC | $59.94 | 2021 | |
| Verity Pharmaceuticals INC. | $33.48 | 2023 | Trelstar |
| Antares Pharma, INC. | $26.29 | 2019-2021 | |
| Clarus Therapeutics INC. | $20.97 | 2021 | |
| Merck Sharp & Dohme LLC | $16.94 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $15.45 | 2019 | |
| Urogen Pharma, INC. | $12.53 | 2021 | |
| Coloplast Corp | $11.41 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.24 | 2019 | |
| Travere Therapeutics, INC. | $9.83 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$524.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.